Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients

NCT00153660 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

514

Enrollment

OTHER

Sponsor class

Conditions

Arthritis
Cardiovascular Diseases
Cerebrovascular Disorders

Interventions

DRUG: Celecoxib(drug)
DRUG: Naproxen(drug)

Sponsor

Chinese University of Hong Kong